Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06248619
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-01-31
Brief Title:
A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
Sponsor:
Organization:
Amgen